Author： Belfayol-Pisanté L.
Publisher： Adis International
ISSN： 1173-2563
Source： Clinical Drug Investigation, Vol.18, Iss.3, 1999-09, pp. : 225-231
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Optimisation of Cyclophosphamide Therapy in Systemic Vasculitis
By Richmond R.
Clinical Pharmacokinetics, Vol. 34, Iss. 1, 1998-01 ,pp. :
Access to resources
Recommend
Bortezomib, cyclophosphamide + prednisone in refractory MM
Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. :
Cyclophosphamide pharmacokinetics in paediatric NHL
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :
Clinical Pharmacokinetics of Cyclophosphamide
Clinical Pharmacokinetics, Vol. 44, Iss. 11, 2005-01 ,pp. :
The eye in systemic vasculitis
By Menezo Victor Lightman Susan
Clinical Medicine, Vol. 4, Iss. 3, 2004-05 ,pp. :